Nectar Lifesciences Limited — Others, 12-07-2025: Copy of Newspaper Publication

Nectar Lifesciences Ltd. has announced a board meeting to consider the financial results for the quarter and half-year. Additionally, the company has scheduled an Extraordinary General Meeting (EGM) to be held at its registered office and works, with remote e-voting facility provided for members to vote on special business resolutions. Shareholders can participate either through remote e-voting or physical ballot at the EGM, with detailed instructions available on the company’s website and KFin Technologies’ portal. This facilitates shareholder engagement and decision-making on key corporate matters.